2 completed, 1 not yet recruiting. 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Placebo only: new trials by email Literature Review of Placebo only trials Research Report on Placebo only
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery Cannabidiol (CBD) only, Placebo only, Delta-9-tetrahydrocannabinol (THC) only - PTSD, Post Traumatic Stress Disorder | Phase 1 / Phase 2 | Not yet recruiting | Leslie Lundahl | 280 | 2026-09-01 | 2026-08-26 |
| A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy Cebranopadol, Oxycodone IR, Placebo Only - Acute Pain | Phase 3 | Completed | Tris Pharma, Inc. | 240 | 2024-07-18 | 2026-01-26 |
| A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD GSK573719/GW642444 125/25mcg, GSK573719 125mcg, GW642444 25mcg - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | GlaxoSmithKline | 1493 | 2011-03-01 | 2018-01-29 |
Acute Pain (1) · Pulmonary Disease, Chronic Obstructive (1) · Stress Disorders, Post-Traumatic (1) · Suicide (1)
GlaxoSmithKline (1) · Leslie Lundahl (1) · Tris Pharma, Inc. (1)
United States (3) · Belgium (1) · Denmark (1) · Estonia (1) · France (1) · Germany (1) · Hungary (1) · Japan (1) · Netherlands (1) · Norway (1) · Philippines (1) · Slovakia (1) · Sweden (1) · Ukraine (1)